de Jonge A, Timmermans P B, van Zwieten P A
Br J Pharmacol. 1983 Mar;78(3):479-87. doi: 10.1111/j.1476-5381.1983.tb08808.x.
1 alpha-Adrenergic activities (hypotension, bradycardia, sedation) and affinities of clonidine and two newly substituted derivatives, 2-(2,3,6-trichlorophenylimino)imidazolidine (I) and 2-(2,3-dichloro-6-methylphenylimino)imidazolidine (II), were determined in various in vitro and in vitro models.2 In anaesthetized normotensive rats, the intravenous -log doses (mol/kg) of clonidine, compound I and II required to decrease mean arterial pressure by 20% were 7.96, 8.39 and 7.79, respectively, and to reduce heart rate by 20% were 7.85, 8.23 and 7.91, respectively. Comparable potencies were obtained in vagotomized rats. Following vertebral arterial infusion of clonidine, compound I and II into anaesthetized cats, the -log doses for 20% diminution in mean arterial pressure were 8.72, 9.17 and 7.92, respectively.3 In pithed normotensive rats, the intravenous -log doses (mol/kg) of clonidine, compound I and II required to elevate diastolic pressure by 50 mmHg were 7.49, 7.80 and 8.04, respectively, whereas 50% of the maximal inhibition of electrical stimulation-induced tachycardia was obtained at -log doses of 8.20, 8.25 and 8.34, respectively.4 In mice, the intraperitoneal -log doses (mol/kg) needed for a prolongation of the hexobarbitone-induced loss of the righting reflex by 100% were 6.51, 6.55 and 6.60 for clonidine, compound I and II, respectively.5 Compounds I and II displayed a higher affinity for alpha(1)- and alpha(2)-adrenoceptors than clonidine, identified in rat cerebral membranes by [(3)H]-prazosin and [(3)H]-clonidine.6 The results show that 2,3,6-trisubstituted derivatives of clonidine are potent alpha-adrenoceptor stimulants. This new class of congeners may have potential for pronounced hypotensive activity following systemic application. It is not likely that among members of this series, hypotensive potency can be separated from sedative activity.
1 在多种体外和体内模型中测定了可乐定以及两种新的取代衍生物2-(2,3,6-三氯苯基亚氨基)咪唑烷(I)和2-(2,3-二氯-6-甲基苯基亚氨基)咪唑烷(II)的α-肾上腺素能活性(低血压、心动过缓、镇静作用)和亲和力。2 在麻醉的正常血压大鼠中,使平均动脉压降低20%所需的可乐定、化合物I和II的静脉注射-log剂量(mol/kg)分别为7.96、8.39和7.79,使心率降低20%所需的剂量分别为7.85、8.23和7.91。在切断迷走神经的大鼠中获得了相当的效能。在麻醉猫的椎动脉内注入可乐定、化合物I和II后,使平均动脉压降低20%的-log剂量分别为8.72、9.17和7.92。3 在脊髓切断的正常血压大鼠中,使舒张压升高50 mmHg所需的可乐定、化合物I和II的静脉注射-log剂量(mol/kg)分别为7.